Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies

Go back to Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies
(AMEX: AVAI) Delayed: 0.12 -0.01 (7.69%)
Previous Close $0.13    52 Week High $ 
Open $0.13    52 Week Low $ 
Day High $0.13    P/E N/A 
Day Low $0.12    EPS $ 
Volume 113,501